James Mackay serves as Executive at BIOFIELD CORP \DE\, where they oversee executive responsibilities. Since joining the company, James Mackay has executed 2 insider transactions totaling $1.7M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jan 17, 2008 involved purchasing 12,300,000 shares valued at $1.2M.
James Mackay currently holds 12,300,000 shares of BIOFIELD CORP \DE\ (BZET.PK), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, James Mackay has been a net buyer of BZET.PK stock. They have purchased $1.7M and sold $0 worth of shares.
James Mackay's most recent insider trade was on Jan 17, 2008, when they purchased 12,300,000 shares at $0.10 per share.
Get notified when new Form 4 filings are submitted
| $0.05 |
| Discretionary |